Application Nr Approved Date Route Status External Links
NDA020379 None Intracavernous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Caverject Is A Prostaglandin E1 Agonist Indicated For The Treatment Of Erectile Dysfunction ( 1.1 ). As An Adjunct To Other Diagnostic Tests In The Diagnosis Of Erectile Dysfunction ( 1.2 ). 1.1 Erectile Dysfunction Caverject Is Indicated For The Treatment Of Erectile Dysfunction. 1.2 Diagnostic Testing For Erectile Dysfunction Caverject Is Indicated As An Adjunct To Other Diagnostic Tests In The Diagnosis Of Erectile Dysfunction.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Alprostadil ALPROSTADIL ZINC3813088

Comments